The CD34 antigen: Potential clinical advantages of CD34 selection

Civin, 1984, Antigenic analysis of hematopoiesis; III. A hematopoietic progenitor cell surface antigen defined by monoclonal antibody raised against KG-1A cells, J Immunol, 133, 157, 10.4049/jimmunol.133.1.157

Andrews, 1986, Monoclonal antibody 12-8 recognizes a 115 kd molecule present on both unipotent and multipotent cololny-forming cells and their precursors, Blood, 67, 842, 10.1182/blood.V67.3.842.842

Katz, 1985, Identification of a membrane glycoprotein associated with haematopoietic progenitor cells, Leuk Res, 9, 191, 10.1016/0145-2126(85)90082-7

Briddell, 1989, Characterization of the human burst-forming unit-megakaryocyte, Blood, 74, 145, 10.1182/blood.V74.1.145.145

Lu, 1987, Characterization of adult human marrow hematopoietic progenitors highly enriched by two-colour sorting with MY-10 and major histo-compatibility class II monoclonal antibodies, J Immunol, 139, 1823, 10.4049/jimmunol.139.6.1823

Katz, 1986, Co-ordinate expression of BI-3C5 and HLA-DR antigens on haemopoietic progenitors from chronic myeloid leukaemia, Leuk Res, 10, 961, 10.1016/0145-2126(86)90249-3

Ryan, 1986, Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens, Blood, 68, 417, 10.1182/blood.V68.2.417.417

Loken, 1987, Flow cytometric analysis of human bone marrow:II. Normal B lymphocyte development, Blood, 70, 1316, 10.1182/blood.V70.5.1316.1316

Kurihara, 1988, Multipotent hematopoietic colony forming cells are early precursors for osteo-clasts, Exp Hematol, 16, 473a

Simmons, 1989, Stromal cell precursors express the CD34 antigen and the receptor for soybean agglutinin, Blood, 74, 151a

Parravicini, 1993, CD34 expression on fibroblastic cells, Tissue Antigens, 42, 392a

Beschorner, 1985, Localization of human hematopoietic progenitor cells in tissue with anti-MY-10 monoclonal antibody, Am J Pathol, 119, 1

Fina, 1990, Expression of the CD34 gene in vascular endothelial cells, Blood, 75, 2417, 10.1182/blood.V75.12.2417.2417

Lee, 1992, The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia, Leukemia, 6, 1203

Geller, 1990, Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: The significance of the stem-cell glyco-protein CD34 (My10), Br J Haematol, 76, 340, 10.1111/j.1365-2141.1990.tb06365.x

te Boekhorst, 1993, Predominance of functional multidrug resistance (MDR-1) phenotype in CD34 positive acute myeloid leukemia cells, Blood, 82, 3157, 10.1182/blood.V82.10.3157.3157

Lamy, 1994, P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML), Leukemia, 8, 1879

Thomas, 1995, CD34 expression is assoicated with major adverse prognostic features in adult acute lymphoblastic leukemia, Leukemia, 9, 249

Gazitt, 1995, Purified CD34 positive Lin-Thy positive stem cells do not contain clonal myeloma cells, Blood, 86, 381, 10.1182/blood.V86.1.381.bloodjournal861381

Vescio, 1994, The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma, Blood, 84, 3283, 10.1182/blood.V84.10.3283.3283

Monihan, 1994, CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses, Histopathology, 25, 469, 10.1111/j.1365-2559.1994.tb00009.x

Miettinen, 1995, Gastrointestinal stromal tumors — value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas, Am J Surg Pathol, 19, 207, 10.1097/00000478-199502000-00009

van de Rijn, 1994, CD34 expression by gastrointestinal tract stromal tumours, Hum Pathol, 25, 766, 10.1016/0046-8177(94)90245-3

Chaubal, 1994, CD34 immuno-reactivity in nervous system tumours, Acta Neuropathol, 88, 454, 10.1007/BF00389498

Suster, 1994, On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations, Am J Dermato-pathol, 16, 355, 10.1097/00000372-199408000-00001

Poblet, 1994, QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumors, J Cutan Pathol, 21, 224, 10.1111/j.1600-0560.1994.tb00264.x

van de Rijn, 1994, Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung, Am J Surg Pathol, 18, 814, 10.1097/00000478-199408000-00008

Schneider, 1994, Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients, Bone Marrow Transplant, 14, 877

Bender, 1994, Guidelines for the determination of CD34+ cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells, 31

Sutherland, 1994, Sensitive detection and enumeration of CD34 positive cells in peripheral and cord blood by flow cytometry, Exp Hematol, 22, 1003

Bender, 1992, Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplant, Bone Marrow Transplant, 10, 281

Berenson, 1988, Antigen CD34-positive marrow cells engraft lethally irradiated baboons, J Clin Invest, 81, 951, 10.1172/JCI113409

Shpall, 1994, Transplantation of enriched CD34 positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34 positive peripheral-blood progenitors and growth factors on engraftment, J Clin Oncol, 12, 28, 10.1200/JCO.1994.12.1.28

Schiller, 1995, Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma, Blood, 86, 390, 10.1182/blood.V86.1.390.bloodjournal861390

Negrin, 1995, Transplantation of enriched and purged peripheral progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma, Blood, 85, 3334, 10.1182/blood.V85.11.3334.bloodjournal85113334

Scheding, 1994, Peripheral blood stem cells: In vivo biology and therapeutic potential, Stem Cells, 12, 203, 10.1002/stem.5530120717

Gorin, 1995, Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma, Blood, 85, 1647, 10.1182/blood.V85.6.1647.bloodjournal8561647

Brugger, 1994, Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin, Blood, 84, 1421, 10.1182/blood.V84.5.1421.1421

Shpall, 1994, Transplantation of CD34+ hematopoietic progenitor cells, J Hematother, 3, 145, 10.1089/scd.1.1994.3.145

Corringham, 1995, Rapid and sustained allogeneic transplantation using immunselected CD34+-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors, Blood, 86, 2052, 10.1182/blood.V86.5.2052a.bloodjournal8652052a

Brenner, 1995, The contribution of marker gene studies to hemopoietic stem cell therapies, Stem Cells, 13, 453, 10.1002/stem.5530130502

Brugger, 1995, Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo, N Engl J Med, 333, 283, 10.1056/NEJM199508033330503

Lebkowski, 1992, Rapid isolation of human CD34 hematopoietic stem cells — purging of human tumor cells, Transplantation, 53, 1011, 10.1097/00007890-199205000-00009

Okarma, 1992, The AIS CELLector: A new technology for stem cell purification, 487

Holyoake, 1994, Efficient isolation of CD34 positive hemopoietic progenitor cells by immune panning, 12, 114

Berenson, 1991, Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma, Blood, 77, 1717, 10.1182/blood.V77.8.1717.1717

Fruehauf, 1994, CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors, Stem Cells, 12, 95, 10.1002/stem.5530120116

Miltenyi, 1990, High gradient magnetic separation with MACS, Cytometry, 11, 231, 10.1002/cyto.990110203

Miltenyi, 1994, Isolation of CD34+ hematopoietic progenitor cells by high-gradient magnetic cell sorting (MACS), 201

de Wynter, 1995, Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems, Stem Cells, 13, 524, 10.1002/stem.5530130510

Shpall, 1994, Release of tumor cells from bone marrow, Blood, 83, 623, 10.1182/blood.V83.3.623.623

Ross, 1993, Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical assay techniques, Blood, 82, 2605, 10.1182/blood.V82.9.2605.2605

Brugger, 1994, Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors, Blood, 83, 636, 10.1182/blood.V83.3.636.636

Moss, 1992, The risk of tumor cell contamination in peripheral blood stem cell collections, J Hematother, 1, 225, 10.1089/scd.1.1992.1.225

Brenner, 1993, Gene-marking to trace origin of relapse after autologous bone-marrow transplantation, Lancet, 341, 85, 10.1016/0140-6736(93)92560-G

Brenner, 1993, Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients, Lancet, 342, 1134, 10.1016/0140-6736(93)92122-A

Deisseroth, 1994, Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML, Blood, 88, 3068, 10.1182/blood.V83.10.3068.3068

Rill, 1994, Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells, Blood, 84, 380, 10.1182/blood.V84.2.380.380

Lemoli, 1994, Positive selection of hematopoietic CD34+ stem cells provides ‘indirect purging’ of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins, Bone Marrow Transplant, 13, 465

Cottier-Fox, 1995, Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T-cell depletion equivalent to elutriation, Exp Hematol, 23, 320

Dreger, 1995, G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1, Exp Hematol, 23, 147

Verdonck, 1994, Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft, Blood, 83, 3090, 10.1182/blood.V83.10.3090.3090

Haylock, 1992, Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage, Blood, 80, 1405, 10.1182/blood.V80.6.1405.bloodjournal8061405

Brugger, 1993, Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1ß(IL-1ß), IL-6, IL-3, interferon-γ and erythropoietin, Blood, 81, 2579, 10.1182/blood.V81.10.2579.2579

Henschler, 1994, Maintenance of transplantation potential in ex vivo expanded CD34+-selected human peripheral blood progenitor cells, Blood, 84, 2898, 10.1182/blood.V84.9.2898.2898

Shapiro, 1994, Optimization of conditions for ex vivo expansion of CD34+ cells from patients with Stage IV breast cancer, Blood, 84, 3567, 10.1182/blood.V84.10.3567.3567

McAlister, 1992, Ex vivo expansion of peripheral blood progenitor cells with recombinant cytokines, Exp Hematol, 20, 626

Brugger, 1995, Ex vivo expansion of peripheral blood CD34+ hematopoietic progenitor cells: Implications for the expansion of contaminating tumor cells, Exp Hematol, 23, 357a

Mackensen, 1995, Delineation of the dendritic cell lineage by generating Birbeck granule-positive Langerhans' cells from human peripheral blood progenitor cells in vitro, Exp Hematol, 23, 240a

Shibuya, 1995, Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells, Blood, 85, 3538, 10.1182/blood.V85.12.3538.bloodjournal85123538

Dunbar, 1995, Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation, Blood, 85, 3048, 10.1182/blood.V85.11.3048.bloodjournal85113048

Nolta, 1995, Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells, Blood, 86, 101, 10.1182/blood.V86.1.101.bloodjournal861101

Kiem, 1995, Gene therapy and bone marrow transplantation, Curr Opin Oncol, 7, 107, 10.1097/00001622-199503000-00003

Dunbar, 1993, Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer, Hum Gene Ther, 4, 205, 10.1089/hum.1993.4.2-205

Blaese, 1990, The ADA human gene therapy clinical protocol, Hum Gene Ther, 1, 327, 10.1089/hum.1990.1.3-327

Blaese, 1993, Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency, Pediatr Res, 33, 49, 10.1203/00006450-199333011-00010

Ward, 1994, Transfer and expression of the human multidrug resistance gene in human CD34+ cells, Bood, 84, 1408

Sorrentino, 1992, Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1, Science, 257, 99, 10.1126/science.1352414